2022-12-9 6:06 Friday Read (8469) Comments (0)
What are the listed companies of new crown antigen detection kit in 2022? According to the small Li financial perspective collection summary, China's A-share market engaged in the new crown antigen detection kit listed companies a **** there are 20, of which 4 listed on the Shanghai Stock Exchange, 16 listed on the Shenzhen Stock Exchange. So, what are the new crown antigen detection kit concept stocks? What are the new crown antigen detection kit leading stocks? The following details.
What are the leading stocks of new crown antigen detection kit?
The new crown antigen detection kit leading stocks are: JiuAn Medical (002432), UW Genetics (300676), Daan Genetics (002030), Wanfu Biological (300482), Oriental Biological (688298) and so on.
New crown antigen detection kit good news:
1, # Guangzhou implementation of classification nucleic acid test, encourage families to prepare their own antigen kit # December 1, Guangzhou City epidemic prevention and control press conference put forward the implementation of the classification of the acid test: the risk of jobs, key personnel to carry out the required frequency of nucleic acid test; for the flow of cross-provincial personnel to carry out the "landing test"; according to the public travel and control of the city of Guangzhou. The "test"; according to the public travel, medical and other daily needs, do a good job of nucleic acid "on-demand testing" services to protect; encourage families to prepare their own antigen kit.
2, antigen kit sales surged more than 400 times, will benefit the new crown antigen detection kit related stocks!
New crown antigen test kit concept stock list list:
1, JiuAn medical (002432), the latest share price of 59.31 yuan, the total market value of 28.567 billion: the company's new crown antigen home self-testing OTC kit products have begun to subsidiary iHealth U.S. in the local to the C end and the B end of the simultaneous sales, the company is actively approaching, follow up! orders from various customers.
2, UW Genetics (300676), the latest share price of 58.87 yuan, total market capitalization of 24.367 billion: the company's holding subsidiary, Shenzhen UW Ingenics Pharmaceutical Science and Technology Co., Ltd. developed a new type of coronavirus antigen detection kit through the State Drug Administration for emergency approval, obtained a medical device registration certificate. The new coronavirus antigen self-testing kit obtained EU CE certificate.
3, Daan gene (002030), the latest share price of 17.36 yuan, a total market value of 24.364 billion: the company's wholly owned subsidiary Zhongshan biological research and development of new coronavirus antigen rapid detection kit (colloidal gold method) have been sent to Hong Kong.
4, Wanfu biological (300482), the latest share price of 47.01 yuan, a total market value of 20.897 billion: Guangzhou antigen pilot supplier, the first batch of new coronary antibody detection kit registration certificate of the company, but also the largest share of the domestic antigen detection company, the important thing is that the company does not have the nucleic acid detection business, focus on antigen detection, is one of the leading enterprises of the domestic POCT. Strong first-mover advantage.
5, Oriental Biological (688298), the latest share price of 109.91 yuan, the total market value of 18.465 billion: the company's new crown antigen detection reagents to take the lead in the European market to promote the use of the world's second, the first domestic company to get the CE certification of the European Union, Oriental Biological by virtue of the excellent technical indicators and stable and reliable quality, widely recognized by the European market. 2021 December 30th, the company has also gained access to the U.S. market. The daily output of Dongfang Bio's new crown antigen detection reagents is over 10 million copies, with a significant advantage in capacity scale.
6, Yafei Long (688575), the latest share price of 24.65 yuan, total market value of 13.977 billion: Yafei Long is China's Hong Kong and domestic antigen reagent manufacturers, mainly engaged in the new crown of the virus SARS-CoV-2 antigen, IgM antibody, IgG antibody, neutralizing antibody detection of a series of diagnostic products developed independently, won the Japanese MBL 337 million yuan new crown of the reagent kit order, the product enjoys a good reputation. The company has won the order of MBL of Japan for 337 million yuan of new crown reagent kits, and its products are popular in Europe and Hong Kong, China, and its market share is at the forefront of the market.
7, Kangtai medicine (300869), the latest share price of 27.17 yuan, the total market value of 10.917 billion: has obtained a new coronavirus antigen test kit, and obtained the European Union CE certification.
8, nine strong biological (300406), the latest share price of 17.46 yuan, a total market capitalization of 10.281 billion: the company's new coronavirus antigen detection kit can detect omicronjon new coronavirus mutant strains. The company's new crown detection reagent products have been sold in Italy and other countries, overseas sales prospects are very optimistic.
9, Mindray Bio (002932), the latest share price of 65.75 yuan, total market capitalization of 10.270 billion: the company's currently approved self-testing products are only new coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) (self-testing version), and the product is only part of the overseas countries to obtain certification.
10, canfu medical (301087), the latest share price of 46.28 yuan, the total market value of 9.649 billion: the company's independent research and development and production of the new crown antigen detection products, antibody detection products and neutralization of antibody detection have been obtained the CE certificate of the European Union and the Ministry of Commerce of the Chinese Ministry of Commerce export white list, has now begun to a small amount of overseas sales.
11, Kemper Bio (300639), the latest share price of 19.75 yuan, total market capitalization of 8.680 billion: the company's independent research and development of the new coronavirus 2019-nCoV nucleic acid detection kit (fluorescent PCR method) is not a new crown antigen detection reagents, the product has now obtained three types of medical device registration certificate, the EU CE certification, Brazil ANVISA certification, Australia TGA certification, DIGEMID (Peruvian Medical Supplies and Drug Administration) certification, COFEPRIS (Mexico Ministry of Health) certification and the Ministry of Health of Ethiopia's registration certification of the product access qualification in many countries and regions, into the World Health Organization (WHO) Emergency Use List (EUL), and has obtained the Guangdong Provincial Drug Administration issued the "Medical Device Product Export Sales Certificate" issued by the Guangdong Provincial Drug Administration, according to the overseas epidemic prevention and control needs, the product has continued to export, the product has been exported to Brazil, Malaysia, Sri Lanka and other countries and regions.
12, Aotai biological (688606), the latest share price of 118.18 yuan, total market capitalization of 6.370 billion: the company as one of the early development of the new coronary antibody detection products in China, in February 2020 successfully developed the development of a new coronary virus (2019-nCoV IgG/IgM) antibody detection kit.
13, Qianhong Pharmaceutical (002550), the latest share price of $ 6.16, total market capitalization of 7.884 billion: has obtained the new coronavirus antigen detection kit, and obtained the European Union CE certification.
14, Tailin Bio (300813), the latest share price of 80.49 yuan, the total market value of 6.693 billion: the company began the development of NC membrane and the first production line construction, and formally put into the small batch production. nc membrane is one of the important raw materials for the new coronary antigen detection kit. According to the company's planning, at present, the company's NC membrane expansion capacity required site construction has been completed, the relevant production equipment has been in place and has completed the installation, part of the equipment is still in the process of further optimization and debugging work, and will be followed by production and stocking according to market demand and orders.
15, Univision (301166), the latest share price of 67.98 yuan, total market capitalization of 5.892 billion: the company is the domestic antigen antibody varieties and specifications of the most comprehensive supplier; the company has the core raw materials for antigen detection of NC membranes and recombinant proteins, the company's products mainly include antibodies and antibody-related reagents, consumables, equipment, products of the integrated technology. The company's antibody-related reagent products include test kits developed based on antibody application technology, recombinant proteins/peptides, and auxiliary reagents. Recombinant proteins are mainly used as additives for cell cultures or as standards for drawing standard curves for quantitative test kits. Our products and services cover all aspects of drug discovery, preclinical research, and clinical research in drug discovery (mainly biologics, such as antibody drugs, recombinant protein drugs, cell therapy, etc.).
16, Huashengchang (002980), the latest share price of 36.91 yuan, total market capitalization of 4.921 billion: coronavirus antigen rapid detection kit products to obtain the European Union CE certification.
17, Yi Chang Technology (002420), the latest share price of 10.66 yuan, a total market capitalization of 4.275 billion: the company's medical parts business is mainly a medical structural components and medical consumables business, the products are the new coronary antigen test card parts, nucleic acid sampling tubes and deep-well plates.
18, shengtong shares (002599), the latest share price of 5.61 yuan, total market capitalization of 3.016 billion: the company's business has to do with the new crown detection packaging, antigen detection packaging, vaccine and antigen detection kit aspects of packaging business of the main customers are China biological, zhifei biological, heat King biological and so on.
19, Seri Medical (603716), the latest share price of 14.08 yuan, total market capitalization of 2.866 billion: the company has a new coronavirus (COVID-19) IgM/IgG antibody detection kit (colloidal gold immunochromatography) production capacity, the reagent has been certified by the European Union CE certification, has been entered into the Ministry of Commerce, the Ministry of Health materials export white list, can be exported to the European Union.
20
20, ST Toyo (002086), the latest share price of 2.91 yuan, total market value of 2.201 billion: the company's wholly-owned subsidiary Aivico Biotechnology Co., Ltd.'s new coronavirus (2019-nCoV) IgM/IgG antibody detection kit (colloidal gold method) has obtained a medical device registration certificate issued by the State Drug Administration.
21, Novozymes (688105): the company's self-developed new coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) has been approved by the State Drug Administration for marketing, for the detection of new coronavirus N antigen and S antigen in the oropharyngeal swabs and nasopharyngeal swabs samples of people suspected of new coronavirus-infected pneumonia.
The above list of "New Coronavirus Antigen Detection Kit Concept Stocks" is sorted by company market capitalization and market share
.